Expertise in
3
conditions

Stephan Tschirdewahn

Essen, NW, DE 
Expertise in
3
conditions
Essen, NW, DE 

Overview

Stephan Tschirdewahn practices practicing medicine in Essen, Germany.

Mr. Tschirdewahn is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Urothelial Cancer, Prostate Cancer, Cystectomy, and Prostatectomy.

He is actively involved in clinical research, co-authoring 58 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Essen, NW 45147, Germany
Other Locations
Kempten (allgaeu), BY, Germany
Heidelberg, BW, Germany
Duisburg, NW, Germany
Berlin, BE, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Prospektiv Randomisierte Multizentrische Phase II-Studie Zur Metastasenresektion Von Lungenfiliae (Poor-prognosis) Beim Klarzelligen Nierenzellkarzinom +/- Adjuvante Sunitinibtherapie über 1 Jahr SMAT - AN 20/04 Der AUO
Prospektiv Randomisierte Multizentrische Phase II-Studie Zur Metastasenresektion Von Lungenfiliae (Poor-prognosis) Beim Klarzelligen Nierenzellkarzinom +/- Adjuvante Sunitinibtherapie über 1 Jahr SMAT - AN 20/04 Der AUO
Enrollment Status: Terminated
Publish Date: August 25, 2026
Intervention Type: Drug
Study Drug: Sunitinib
Study Phase: Phase 2
Intravesical Mistletoe Extract in Superficial Bladder Cancer: A Phase III Efficacy Study
Intravesical Mistletoe Extract in Superficial Bladder Cancer: A Phase III Efficacy Study
Enrollment Status: Terminated
Publish Date: May 22, 2026
Intervention Type: Drug
Study Drugs: abnobaVISCUM 900, Mitomycin C
Study Phase: Phase 3
View 1 Less Clinical Trial

58 Total Publications

68Ga-FAPI and 18F-FAPI PET/CT for detection of nodal metastases prior radical cystectomy in high-risk urothelial carcinoma patients.
68Ga-FAPI and 18F-FAPI PET/CT for detection of nodal metastases prior radical cystectomy in high-risk urothelial carcinoma patients.
Journal: European journal of nuclear medicine and molecular imaging
Published: December 10, 2024

Frequently Asked Questions about Stephan Tschirdewahn

Is Stephan Tschirdewahn a top-rated expert for Bladder Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Stephan Tschirdewahn is classified as an Advanced expert for Bladder Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Stephan Tschirdewahn participate in research or clinical trials?

Yes. Stephan Tschirdewahn has published 58 articles and abstracts on conditions like Bladder Cancer. You can view a list of Stephan Tschirdewahn's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Tschirdewahn's expertise for a condition
ConditionClose
      View All 8 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile